{"entity":{"type":"insider","cik":"0001362635","url":"/insider/0001362635","json_url":"/insider/0001362635.json","name":"Lenk Robert P","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":13,"n_filings":9,"first":"2020-08-26","last":"2025-08-25","span_basis":"filed_date"},"name_variants":[{"name":"Lenk Robert P","source":"filing","n_filings":9,"first_seen":"2020-08-26","last_seen":"2025-08-25"}],"transactions":[{"id":5119000,"accession":"0000950170-25-111092","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-111092","line_url":"/filing/0000950170-25-111092#line-1","is_derivative":false,"issuer_cik":"0001095981","issuer_name":"PLUS THERAPEUTICS, INC.","issuer_ticker":"PSTV","issuer_name_source":null,"issuer_url":"/issuer/0001095981","owner_cik":"0001362635","owner_name":"Lenk Robert P","owner_display_name":"Lenk Robert P","owner_url":"/insider/0001362635","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":110000.0,"shares_display":"110,000","price_per_share":0.4889,"price_display":"0.49","price_state":"stated","total_value":53779.0,"total_display":"53,779.00","total_whole":"53,779","shares_owned_after":139327.0,"shares_owned_after_display":"139,327","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-22","filed_date":"2025-08-25","scope":"insider"},{"id":3020468,"accession":"0000950170-24-057451","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-057451","line_url":"/filing/0000950170-24-057451#line-1","is_derivative":false,"issuer_cik":"0001095981","issuer_name":"PLUS THERAPEUTICS, INC.","issuer_ticker":"PSTV","issuer_name_source":null,"issuer_url":"/issuer/0001095981","owner_cik":"0001362635","owner_name":"Lenk Robert P","owner_display_name":"Lenk Robert P","owner_url":"/insider/0001362635","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4167.0,"shares_display":"4,167","price_per_share":2.04,"price_display":"2.04","price_state":"stated","total_value":8500.68,"total_display":"8,500.68","total_whole":"8,501","shares_owned_after":29327.0,"shares_owned_after_display":"29,327","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-08","filed_date":"2024-05-10","scope":"insider"},{"id":8117191,"accession":"0001209191-23-055638","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-055638","line_url":"/filing/0001209191-23-055638#line-2","is_derivative":false,"issuer_cik":"0001095981","issuer_name":"PLUS THERAPEUTICS, INC.","issuer_ticker":"PSTV","issuer_name_source":null,"issuer_url":"/issuer/0001095981","owner_cik":"0001362635","owner_name":"Lenk Robert P","owner_display_name":"Lenk Robert P","owner_url":"/insider/0001362635","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":1.95,"price_display":"1.95","price_state":"stated","total_value":1950.0,"total_display":"1,950.00","total_whole":"1,950","shares_owned_after":25160.0,"shares_owned_after_display":"25,160","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-16","filed_date":"2023-11-17","scope":"insider"},{"id":8117187,"accession":"0001209191-23-055638","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-055638","line_url":"/filing/0001209191-23-055638#line-1","is_derivative":false,"issuer_cik":"0001095981","issuer_name":"PLUS THERAPEUTICS, INC.","issuer_ticker":"PSTV","issuer_name_source":null,"issuer_url":"/issuer/0001095981","owner_cik":"0001362635","owner_name":"Lenk Robert P","owner_display_name":"Lenk Robert P","owner_url":"/insider/0001362635","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":1.77,"price_display":"1.77","price_state":"stated","total_value":1770.0,"total_display":"1,770.00","total_whole":"1,770","shares_owned_after":24160.0,"shares_owned_after_display":"24,160","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-15","filed_date":"2023-11-17","scope":"insider"},{"id":8023639,"accession":"0001209191-23-055264","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-055264","line_url":"/filing/0001209191-23-055264#line-2","is_derivative":false,"issuer_cik":"0001095981","issuer_name":"PLUS THERAPEUTICS, INC.","issuer_ticker":"PSTV","issuer_name_source":null,"issuer_url":"/issuer/0001095981","owner_cik":"0001362635","owner_name":"Lenk Robert P","owner_display_name":"Lenk Robert P","owner_url":"/insider/0001362635","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":1.43,"price_display":"1.43","price_state":"stated","total_value":5720.0,"total_display":"5,720.00","total_whole":"5,720","shares_owned_after":23160.0,"shares_owned_after_display":"23,160","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-13","filed_date":"2023-11-15","scope":"insider"},{"id":8023637,"accession":"0001209191-23-055264","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-055264","line_url":"/filing/0001209191-23-055264#line-1","is_derivative":false,"issuer_cik":"0001095981","issuer_name":"PLUS THERAPEUTICS, INC.","issuer_ticker":"PSTV","issuer_name_source":null,"issuer_url":"/issuer/0001095981","owner_cik":"0001362635","owner_name":"Lenk Robert P","owner_display_name":"Lenk Robert P","owner_url":"/insider/0001362635","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":1.45,"price_display":"1.45","price_state":"stated","total_value":2900.0,"total_display":"2,900.00","total_whole":"2,900","shares_owned_after":19160.0,"shares_owned_after_display":"19,160","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-10","filed_date":"2023-11-15","scope":"insider"},{"id":8753771,"accession":"0001209191-23-054914","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-054914","line_url":"/filing/0001209191-23-054914#line-2","is_derivative":false,"issuer_cik":"0001095981","issuer_name":"PLUS THERAPEUTICS, INC.","issuer_ticker":"PSTV","issuer_name_source":null,"issuer_url":"/issuer/0001095981","owner_cik":"0001362635","owner_name":"Lenk Robert P","owner_display_name":"Lenk Robert P","owner_url":"/insider/0001362635","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4199.0,"shares_display":"4,199","price_per_share":1.59,"price_display":"1.59","price_state":"stated","total_value":6676.41,"total_display":"6,676.41","total_whole":"6,676","shares_owned_after":17160.0,"shares_owned_after_display":"17,160","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-09","filed_date":"2023-11-13","scope":"insider"},{"id":8753768,"accession":"0001209191-23-054914","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-054914","line_url":"/filing/0001209191-23-054914#line-1","is_derivative":false,"issuer_cik":"0001095981","issuer_name":"PLUS THERAPEUTICS, INC.","issuer_ticker":"PSTV","issuer_name_source":null,"issuer_url":"/issuer/0001095981","owner_cik":"0001362635","owner_name":"Lenk Robert P","owner_display_name":"Lenk Robert P","owner_url":"/insider/0001362635","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":1.65,"price_display":"1.65","price_state":"stated","total_value":8250.0,"total_display":"8,250.00","total_whole":"8,250","shares_owned_after":12961.0,"shares_owned_after_display":"12,961","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-08","filed_date":"2023-11-13","scope":"insider"},{"id":7899908,"accession":"0001209191-23-054650","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-054650","line_url":"/filing/0001209191-23-054650#line-2","is_derivative":false,"issuer_cik":"0001095981","issuer_name":"PLUS THERAPEUTICS, INC.","issuer_ticker":"PSTV","issuer_name_source":null,"issuer_url":"/issuer/0001095981","owner_cik":"0001362635","owner_name":"Lenk Robert P","owner_display_name":"Lenk Robert P","owner_url":"/insider/0001362635","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6000.0,"shares_display":"6,000","price_per_share":1.64,"price_display":"1.64","price_state":"stated","total_value":9840.0,"total_display":"9,840.00","total_whole":"9,840","shares_owned_after":7961.0,"shares_owned_after_display":"7,961","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-07","filed_date":"2023-11-08","scope":"insider"},{"id":7899904,"accession":"0001209191-23-054650","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-054650","line_url":"/filing/0001209191-23-054650#line-1","is_derivative":false,"issuer_cik":"0001095981","issuer_name":"PLUS THERAPEUTICS, INC.","issuer_ticker":"PSTV","issuer_name_source":null,"issuer_url":"/issuer/0001095981","owner_cik":"0001362635","owner_name":"Lenk Robert P","owner_display_name":"Lenk Robert P","owner_url":"/insider/0001362635","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1395.0,"shares_display":"1,395","price_per_share":1.5,"price_display":"1.50","price_state":"stated","total_value":2092.5,"total_display":"2,092.50","total_whole":"2,093","shares_owned_after":1961.0,"shares_owned_after_display":"1,961","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-06","filed_date":"2023-11-08","scope":"insider"},{"id":7829398,"accession":"0001209191-23-001447","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-001447","line_url":"/filing/0001209191-23-001447#line-1","is_derivative":false,"issuer_cik":"0001095981","issuer_name":"PLUS THERAPEUTICS, INC.","issuer_ticker":"PSTV","issuer_name_source":null,"issuer_url":"/issuer/0001095981","owner_cik":"0001362635","owner_name":"Lenk Robert P","owner_display_name":"Lenk Robert P","owner_url":"/insider/0001362635","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":0.3147,"price_display":"0.31","price_state":"stated","total_value":472.05,"total_display":"472.05","total_whole":"472","shares_owned_after":8500.0,"shares_owned_after_display":"8,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-30","filed_date":"2023-01-04","scope":"insider"},{"id":4236185,"accession":"0001209191-21-056096","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-056096","line_url":"/filing/0001209191-21-056096#line-1","is_derivative":false,"issuer_cik":"0001095981","issuer_name":"PLUS THERAPEUTICS, INC.","issuer_ticker":"PSTV","issuer_name_source":null,"issuer_url":"/issuer/0001095981","owner_cik":"0001362635","owner_name":"Lenk Robert P","owner_display_name":"Lenk Robert P","owner_url":"/insider/0001362635","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7000.0,"shares_display":"7,000","price_per_share":1.8587,"price_display":"1.86","price_state":"stated","total_value":13010.9,"total_display":"13,010.90","total_whole":"13,011","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-13","filed_date":"2021-09-15","scope":"insider"},{"id":2443531,"accession":"0001209191-20-048319","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-048319","line_url":"/filing/0001209191-20-048319#line-1","is_derivative":false,"issuer_cik":"0001095981","issuer_name":"PLUS THERAPEUTICS, INC.","issuer_ticker":"PSTV","issuer_name_source":null,"issuer_url":"/issuer/0001095981","owner_cik":"0001362635","owner_name":"Lenk Robert P","owner_display_name":"Lenk Robert P","owner_url":"/insider/0001362635","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":2.4883,"price_display":"2.49","price_state":"stated","total_value":7464.9,"total_display":"7,464.90","total_whole":"7,465","shares_owned_after":3000.0,"shares_owned_after_display":"3,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-25","filed_date":"2020-08-26","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":13,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":12,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":13},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001095981","name":"PLUS THERAPEUTICS, INC.","url":"/issuer/0001095981","role":"Director","n_filings":9,"first_seen":"2020-08-26","last_seen":"2025-08-25"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001362635","retrieved_at":"2026-08-27T00:54:14+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}